Tara Frenkl, MD, MPH is the Head of Oncology Development at Bayer’s Oncology Strategic Business Unit. Prior to joining Bayer, she held the role of Senior Vice President, Head of Medicine Development Leaders in Oncology at GlaxoSmithKline, with strategic impact on the global development of medicines across the company’s oncology portfolio. Prior to joining GlaxoSmithKline, Tara Frenkl was at Merck & Co., Inc. for 13 years in roles of increasing responsibility.